There are 2949 resources available
Summary and close
Presenter: James Larkin
Session: Bristol Myers Squibb - Melanoma in 2020: Reflect, reset, and continue
Resources:
Webcast
Welcome and Introductions
Presenter: Martin Reck
Session: Bristol Myers Squibb - Exploring the current and evolving landscape in thoracic cancers
Resources:
Webcast
Management of Metastatic NSCLC in the Era of I-O
Presenter: Martin Reck
Session: Bristol Myers Squibb - Exploring the current and evolving landscape in thoracic cancers
Resources:
Webcast
Evolving Treatment Landscape of Non-Metastatic NSCLC With I-O
Presenter: Tina Cascone
Session: Bristol Myers Squibb - Exploring the current and evolving landscape in thoracic cancers
Resources:
Webcast
Role of I-O in the Mesothelioma Treatment Landscape
Presenter: Paul Baas
Session: Bristol Myers Squibb - Exploring the current and evolving landscape in thoracic cancers
Resources:
Webcast
Closing and Summary
Presenter: Martin Reck
Session: Bristol Myers Squibb - Exploring the current and evolving landscape in thoracic cancers
Resources:
Webcast
Welcome and introduction
Presenter: Gerald Prager
Session: Servier - Joining efforts beyond first-line management in patients with metastatic pancreatic cancer
Resources:
Webcast
Tumor Registry Pancreatic Cancer: A national registry for the evaluation of treatment strategies in pancreatic cancer
Presenter: Norbert Marschner
Session: Servier - Joining efforts beyond first-line management in patients with metastatic pancreatic cancer
Resources:
Webcast
Summary, final thoughts, and audience question and answer session
Presenter: Ghassan Abou-Alfa
Session: AstraZeneca - Current status and future directions for immunotherapy in hepatocellular carcinoma
Resources:
Webcast
Looking to the future: How can emerging therapeutic options influence the management landscape?
Presenter: Benjamin Besse
Session: Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon
Resources:
Webcast